![Active Biotech Regains Rights to Laquinimod from Teva, Plans to Continue Work on Potential MS Oral Therapy Active Biotech Regains Rights to Laquinimod from Teva, Plans to Continue Work on Potential MS Oral Therapy](https://multiplesclerosisnewstoday.com/wp-content/uploads/2018/09/shutterstock_312808652-1200x675-cropped.jpg)
Active Biotech Regains Rights to Laquinimod from Teva, Plans to Continue Work on Potential MS Oral Therapy
78% Off Arpeggio Knitwear Women's Pullover Sweaters - Pale Dawn Wool-Blend Mock Neck Pullover - Women
Spectacular Sales for Arpeggio Knitwear Women's Cardigans EBONY - Ebony Chenille Open Cardigan - Women
78% Off Arpeggio Knitwear Women's Pullover Sweaters - Pale Dawn Wool-Blend Mock Neck Pullover - Women
![Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study - The Lancet Neurology Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2053239571/2060116772/gr1.gif)
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study - The Lancet Neurology
![Teva and Active Biotech enrol first patient in Laquinimod Phase II trial for PPMS - Clinical Trials Arena Teva and Active Biotech enrol first patient in Laquinimod Phase II trial for PPMS - Clinical Trials Arena](https://www.drugdevelopment-technology.com/wp-content/uploads/image-digitalinsightresearch/Archive/nri/Drug%20development/MS%20Demyelinisation.jpg)